Investor Relations

Investor FAQs

Who is Millendo Therapeutics?
Millendo Therapeutics is a late-stage biopharmaceutical company focused on developing novel treatments for orphan endocrine diseases where current therapies do not exist or are insufficient. The Company’s objective is to build a leading endocrine company that creates distinct and transformative treatments for a wide range of endocrine diseases where there is a significant unmet medical need. The Company is currently advancing livoletide for the treatment of Prader-Willi syndrome and nevanimibe for the treatment of classic congenital adrenal hyperplasia and endogenous Cushing’s syndrome.
Where is Millendo Therapeutics corporate headquarters?
Millendo Therapeutics’ corporate headquarters are located at 301 N. Main St., Suite 100 Ann Arbor, MI 48104. The main office phone number is (734) 845-9000.
Where is the company incorporated?
What is Millendo Therapeutics’ fiscal year?
December 31.
Where is Millendo Therapeutics’ stock traded and what is the stock symbol?
Millendo Therapeutics’ common stock is traded on the Nasdaq Capital Market under the symbol MLND.
Does Millendo Therapeutics’ pay dividends?
Millendo Therapeutics does not anticipate paying any cash dividends in the foreseeable future.
Who is Millendo Therapeutics’ transfer agent?

The transfer agent and registrar for Millendo Therapeutics’ common stock is:

Computershare Trust Company, N.A.
P.O. Box 43078
Providence, RI 02940

How do I transfer stock, change the address on my shareholder account, or replace a lost stock certificate?

All questions regarding ownership of Millendo Therapeutics’ common stock should be addressed to the appropriate transfer agent:

Computershare Trust Company, N.A.
P.O. Box 43078
Providence, RI 02940

Does Millendo Therapeutics have a direct stock purchase plan?
Millendo Therapeutics does not offer a direct stock purchase plan.
Who is Millendo Therapeutics’ independent accountants?
Ernst & Young
171 Monroe Ave NW # 600
Grand Rapids, MI, 49503
Who is Millendo Therapeutics’ legal counsel?
Cooley LLP
500 Boylston Street
Boston, MA 02116-3736
Where can I find more information about Millendo Therapeutics, including its SEC filings?
Our website is the best place; located at The investor section contains all the latest press releases and SEC filings.
How do I obtain further information or materials on Millendo Therapeutics?
For general inquiries, please contact For media requests, please contact
How can I receive email updates about Millendo Therapeutics?
Please sign up for alerts using the button at the bottom of this page.
Who should I contact regarding investor inquiries?
Investor inquiries should be direct to Stephanie Ascher,, 212-362-1200.